Drugs being developed under the AYUSH system of medicine, Check out details

Published On 2017-04-03 06:02 GMT   |   Update On 2017-04-03 06:02 GMT

Central Council for Research in Ayurvedic Sciences (CCRAS) has developed anti-diabetic drug AYUSH-82 and AYUSH-SG for Rheumetoid Arthritis. Central Council for Research in Homoeopathy (CCRH) has developed 9 drugs out of which 2 are of vegetable origin, 5 are from different strains of Dengue virus and two are of chemical origin. Central Council for Research in Siddha (CCRS) has developed D-5 choornam for the management of Type II Diabetes. In addition Ministry of AYUSH through its Research Councils has undertaken R&D for development of new AYUSH drugs with details as under:-


Ayurveda


1. Ayush-QOL RC for improvement of quality of life in cancer patients
2. Ayush- Manas for Mental retardation in Children
3. C-1 oil for wound healing
4. Ayush- Rasayan – A&B for Geriatric Health,
5. Ayush – D for Diabetes,
6. Ayush – A for Asthma,
7. Ayush – PJ – 7 for Dengue


Unani


The Central Council for Research in Unani Medicine (CCRUM) has conducted multi centric clinical trials on four new Unani formulations on Vitiligo, Diabetes Mellitus type – II, Essential Hypertension and Infective Hepatitis. Experimental safety of these drugs has already been established.


The development of new drugs is a standard procedure which involves standardization of raw drug followed by Drug proving, Clinical Verification and Clinical Trial and the whole process takes 7 to 8 years or even more.


This information was given by the Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in written reply to a question in Lok Sabha today.

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News